The introduction of glucagon-like peptide-1 (GLP-1) receptor agonists, corresponding to semaglutide (Ozempic and Wegovy) is a breakthrough within the administration of weight problems....
By JOSHUA SEIDMAN
In 2023, U.S. Surgeon Common Vivek Murthy boldly declared that our nation has a “loneliness epidemic.” Within the Surgeon Common’s public...